A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease.

Strange, Charlie; Walker, Valery; Tong, Junliang; Kurlander, Jonathan; Carlyle, Maureen; Millette, Lauren A; Wittbrodt, Eric

Strange, Charlie; Walker, Valery; Tong, Junliang; Kurlander, Jonathan; Carlyle, Maureen; Millette, Lauren A; Wittbrodt, Eric.

Afiliação

Strange C; Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston.
Walker V; Optum, Inc., Eden Prairie, Minnesota.
Tong J; Optum, Inc., Eden Prairie, Minnesota.
Kurlander J; Optum, Inc., Eden Prairie, Minnesota.
Carlyle M; Optum, Inc., Eden Prairie, Minnesota.
Millette LA; AstraZeneca, Wilmington, Delaware.
Wittbrodt E; AstraZeneca, Wilmington, Delaware.

Chronic Obstr Pulm Dis ; 6(3): 221-232, 2019 Jul 24.

Article em En | MEDLINE | ID: mdl-31342728

Palavras-chave

LABA; LAMA; LAMA/LABA; administrative claims; chronic obstructive pulmonary disease; copd; fixed-dose combination; long-acting beta2-agonist; long-acting muscarinic antagonist; retrospective analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article